Search engine for discovering works of Art, research articles, and books related to Art and Culture
ShareThis
Javascript must be enabled to continue!

Upgrade pacemaker to CRT: predictors and the importance of LVEF

View through CrossRef
Abstract Funding Acknowledgements Type of funding sources: None. Introduction Nowadays 10-15% of CRT implantaon is upgrading from paents (pts) with pacemaker (PMK) who develop reduced LVEF and worsening symptoms from HF. There are few retrospecve studies showing some predictors of pts with single or dual chamber PMK that may need upgrade to CRT, but it is not completely established which pts may benefit the most. Purpose To identify predictors at follow-up of upgrading pacemaker to CRT in a population with pacemaker implantation. Methods Single center case-control study of pts that performed upgrading to CRT-pacemaker (CRT-P) in our hospital. We excluded pts that performed upgrade to CRT-D. We compare to a PMK populaon matched to age at implantaon and cause of PMK implantaon. Demographic, clinic and electrocardiographic (ECG) data were considered at baseline. Echocardiographic evaluation was performed before pacemaker/CRT upgrading implantaon and at follow-up. Predictors of upgrading were evaluated by the Cox regression. Prognosc impact of LVEF was evaluated as upgrading to CRT-P by Kaplan-Meier curves. Results We included 71 pts that performed CRT-P upgrade (mean age 77±10; 49,6% male, mean LVEF before PMK 54.9±9.2%) and 71 pts with pacemaker implantaon (mean age 78 ± 11; 50,4% male; mean LVEF 60.9±7.2%). The clinical characteriscs, ECG and echocardiographic were similar between pacemaker and CRT-P-upgrade, except atrial fibrillaon being more prevalent in PMK group (57.5% vs 42.5% p=0.039). Mortality was not different duringfollow-up between the two groups. In univariate analysis, QRS duraon (PMK: 115ms vs upgrade CRT-P: 132 ms, p=0.038), LVEF (PMK: 60.9% vs upgrade CRT-P: 54.9%, p=0.002) and LV end-diastolic diameter (LVEDD) (PMK: 48.9.4 ± 6.6mm vs upgrade CRT-P: 56.4 ± 6.6mm, p=0.001), LV end-sistolic diameter (LVESD) (PMK: 29.5 ± 6.5mm vs upgrade CRT-P: 37.9 ± 9 mm, p=0.006) were associate to upgrading to CRT. In our population, the unique independent predictor was lower LVEF(Long Rank 6.108, p=0.013) – Figure 1. The best LVEF cut- off to predict upgradingto CRT was 55% (AUC 0.954, sensitivity 64%, specificity 84%) – Figure 2. Conclusion In our populaon of CRT upgrading pts, a broad QRS duraon, lower LVEF and a higher LVEDD and LVESD were associated to upgrade to CTR-P. We try to establish a new value for LVEF that could lead to upgradingto CRT-P, and maybe the classical cut-off of 50% should be reviewed.
Title: Upgrade pacemaker to CRT: predictors and the importance of LVEF
Description:
Abstract Funding Acknowledgements Type of funding sources: None.
Introduction Nowadays 10-15% of CRT implantaon is upgrading from paents (pts) with pacemaker (PMK) who develop reduced LVEF and worsening symptoms from HF.
There are few retrospecve studies showing some predictors of pts with single or dual chamber PMK that may need upgrade to CRT, but it is not completely established which pts may benefit the most.
Purpose To identify predictors at follow-up of upgrading pacemaker to CRT in a population with pacemaker implantation.
Methods Single center case-control study of pts that performed upgrading to CRT-pacemaker (CRT-P) in our hospital.
We excluded pts that performed upgrade to CRT-D.
We compare to a PMK populaon matched to age at implantaon and cause of PMK implantaon.
Demographic, clinic and electrocardiographic (ECG) data were considered at baseline.
Echocardiographic evaluation was performed before pacemaker/CRT upgrading implantaon and at follow-up.
Predictors of upgrading were evaluated by the Cox regression.
Prognosc impact of LVEF was evaluated as upgrading to CRT-P by Kaplan-Meier curves.
Results We included 71 pts that performed CRT-P upgrade (mean age 77±10; 49,6% male, mean LVEF before PMK 54.
9±9.
2%) and 71 pts with pacemaker implantaon (mean age 78 ± 11; 50,4% male; mean LVEF 60.
9±7.
2%).
The clinical characteriscs, ECG and echocardiographic were similar between pacemaker and CRT-P-upgrade, except atrial fibrillaon being more prevalent in PMK group (57.
5% vs 42.
5% p=0.
039).
Mortality was not different duringfollow-up between the two groups.
In univariate analysis, QRS duraon (PMK: 115ms vs upgrade CRT-P: 132 ms, p=0.
038), LVEF (PMK: 60.
9% vs upgrade CRT-P: 54.
9%, p=0.
002) and LV end-diastolic diameter (LVEDD) (PMK: 48.
9.
4 ± 6.
6mm vs upgrade CRT-P: 56.
4 ± 6.
6mm, p=0.
001), LV end-sistolic diameter (LVESD) (PMK: 29.
5 ± 6.
5mm vs upgrade CRT-P: 37.
9 ± 9 mm, p=0.
006) were associate to upgrading to CRT.
In our population, the unique independent predictor was lower LVEF(Long Rank 6.
108, p=0.
013) – Figure 1.
The best LVEF cut- off to predict upgradingto CRT was 55% (AUC 0.
954, sensitivity 64%, specificity 84%) – Figure 2.
Conclusion In our populaon of CRT upgrading pts, a broad QRS duraon, lower LVEF and a higher LVEDD and LVESD were associated to upgrade to CTR-P.
We try to establish a new value for LVEF that could lead to upgradingto CRT-P, and maybe the classical cut-off of 50% should be reviewed.

Related Results

GW24-e3774 Therapeutic effect of cardiac resynchronisation therapy about congestive heart failure
GW24-e3774 Therapeutic effect of cardiac resynchronisation therapy about congestive heart failure
Objectives The aim of this study is to observe the effect of 12 months after therapy of CRT in patients with congestive heart failure, to investigate the change o...
Impact of non-typical LBBB on CRT response
Impact of non-typical LBBB on CRT response
Abstract Introduction Cardiac resynchronization therapy (CRT) benefits have been established in patients with heart failure and ...

Back to Top